Q4 2020 Melexis NV Earnings Call Transcript
Hello, and welcome to the Melexis full year 2020 results. My name is Judy, and I'll be the coordinator for today's event. Please note that the call is being recorded. (Operator Instructions)
I will now hand you over to your host, Francoise Chombar, CEO, to begin today's conference. Thank you.
Thank you, operator. Dear audience, I sincerely hope that you and your close ones are all healthy and well. Thank you for joining the Melexis Fourth Quarter and Full Year 2020 Earnings Call.
Next, to new hopes for the vaccine, the new Year is bringing new opportunities. And together with Karen Van Griensven, our CFO, we'll be glad to talk to you about both the past and the future and answer any question you might have.
During the pandemic, the Melexis values were and are our best vaccine, and that shows in our 2020 results. Thanks to the proactive supply chain and inventory management that Melexis adopted and that allowed us to already sequentially grow 21% in sales for the third
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |